Nasdaq GlobeNewswire

Percona Offers New Services and Software Products to Help Organizations Achieve Performant, Durable Database Environments

Del

Percona's Expertise in Platform as a Service, Database as a Service and More Enables Administrators to Ensure Optimal Performance While Shifting Focus to More Strategic Tasks

RALEIGH, N.C., April 26, 2018 (GLOBE NEWSWIRE) -- Percona, the company that delivers enterprise-class MySQL®, MariaDB®, MongoDB®, PostgreSQL, and other open source database solutions and services, announced new services and software products, including a new Percona DBA service, new support tiers, and the general availability of Percona Server for MongoDB 3.6, the latest version of Percona's free, enhanced, drop-in replacement for the MongoDB Community Edition.

As open source databases are now standard in the enterprise, mission-critical data workloads, whether on-premises or in the cloud, require expert DBAs for architectural decisions, performance tuning, security compliance, and query optimization, as well as monitoring and alert response. Percona has helped thousands of customers achieve better performance, better cost savings and better ROI by ensuring optimal performance while letting DBAs shift their focus to improving applications and better supporting their business.

Organizations are increasingly looking to deploy these open source databases in public cloud environments to benefit from the flexibility, scalability and economics of cloud deployments. Today's announcements reflect Percona's commitment to making it easier for organizations to take advantage of the cloud by providing comprehensive support for migrating open source databases to the cloud and providing support and DBA services specifically designed for the evolving role of database administrators.

Percona DBA Service
Percona DBA Service is a flexible managed database service that offers a guaranteed set of scheduled, proactive deliverables. With the collective experience of a global team of experts to manage high performance relational database environments in on-premises and cloud environments, Percona DBA Service provides performance tuning, growth planning, security assessments, health monitoring and reporting, 24x7x365 responsive services, business continuity reviews and more.

Cloud services like Amazon Aurora, Amazon RDS, Google Cloud and Microsoft Azure are easy to set up, operate and scale, and provide cost-efficient and resizable capacity while automating time-consuming administrative tasks. However, mission-critical databases deployed in DBaaS environments still require important architectural decisions, performance tuning, security compliance and query optimization, as well as monitoring and alert response. Percona DBA Service for Amazon Aurora, Amazon RDSGoogle Cloud and Microsoft Azure offer peace of mind that the database architecture is being proactively managed and improved.

New Support Tiers
Percona's new Essential, Standard and Premium Support tiers provide unbiased, comprehensive, responsive and cost-effective database subscriptions for MySQL, MariaDB, MongoDB and PostgreSQL open source databases. Available 24x7x365, Percona Support helps organizations navigate complexity and mitigate risks using best-of-breed open source software, avoiding vendor lock-in.

In addition, Percona is launching new DBaaS-focused support tiers that align with the changing role of database administrators who manage cloud environments. These administrators require less support for the routine management of operational tasks that are automated in the cloud, allowing Percona to reduce costs while still providing unbiased consultative support services to help customers properly configure their instances, improve schemas, tune queries, diagnose problems, benefit from additional database features, and ultimately get more out of their deployments.

The new support tiers will be available starting July 1, 2018.

Percona Server for MongoDB 3.6.
Percona has announced the general availability of Percona Server for MongoDB 3.6, the latest version of the company's free, enhanced, drop-in replacement for MongoDB Community Edition. Percona Server for MongoDB 3.6 contains all the new features introduced in MongoDB Community Edition 3.6, including:

  • Retryable writes, which ensures data is written to the database even after a network error occurs
  • Causal consistency, which allows reliable reads from secondary nodes
  • Security enhancements, including improved network listening and more restrictive access controls
  • Aggregation and array improvements, for greater querying flexibility

With more than 300,000 downloads, Percona Server for MongoDB provides all the cost and agility benefits of free, proven open source software, along with practical enterprise features. The greater security, reliability and flexibility of Percona Server for MongoDB 3.6 makes it ideal for running the document-based NoSQL MongoDB database in production environments to support product catalogs, online shopping carts, Internet of Things (IoT) applications, mobile/social apps and more.

Quotes

Peter Zaitsev,  Co-founder and CEO of Percona
"Mission-critical database workloads require expertise to ensure resources are being used to their best advantage to obtain the highest possible application performance. Percona is expanding and evolving our offerings to ensure organizations have a hands-on partner, with enterprise-ready products, tools and services, to ensure a consistently performing and durable database environment."

Company Information

Press Contact
Brigit Valencia
For Percona
(360) 597-4516
bdbvalencia@gmail.com 

About Percona

With more than 3,000 customers worldwide, Percona is the only company that delivers enterprise-class solutions for MySQL® , MariaDB®, MongoDB® ,and PostgreSQL across traditional and cloud-based platforms. The company provides SoftwareSupportConsulting, and Managed Services to large, well-known global brands such as Cisco Systems, Time Warner Cable, Alcatel-Lucent, Rent the Runway and the BBC, as well as smaller enterprises looking to maximize application performance while streamlining database efficiencies. Well established as thought leaders, Percona experts author content for the Percona Database Performance Blog and the Percona Live Open Source Database Conferences draw attendees and expert technical speakers from around the world. For more information, visit www.percona.com.

Percona® is a registered trademark of Percona LLC. All other registered and unregistered trademarks in this document are the sole property of their respective owners.




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Percona via Globenewswire

Om Nasdaq GlobeNewswire

Nasdaq GlobeNewswire
Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

+1 212 401 8700http://www.nasdaqomx.com

NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.

Følg saker fra Nasdaq GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Nasdaq GlobeNewswire

Checkpoint Therapeutics Announces Presentation of Updated Data from Phase 1/2 Trial of EGFR Inhibitor CK-10125.9.2018 14:00Pressemelding

Data were featured in an oral presentation at the IASLC 19th World Conference on Lung Cancer Phase 3 trial in treatment-naïve EGFR mutation-positive NSCLC patients targeted to commence in 2019 NEW YORK, Sept. 25, 2018 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immuno-oncology biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for patients with solid tumor cancers, today announced that positive preliminary safety and efficacy data from an ongoing Phase 1/2 clinical trial of CK-101 were presented yesterday in an oral presentation at the International Association for the Study of Lung Cancer (IASLC) 19th World Conference on Lung Cancer in Toronto. The oral presentation included further details on, and updates from, the dataset announced previously. CK-101 is a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) being evaluated in advanced non

SpeeDx Begins Multisite U.S. Clinical Trials of ResistancePlus® MG Test25.9.2018 14:00Pressemelding

Test supports international guidelines for treating antibiotic resistant STI SYDNEY, Australia, Sept. 25, 2018 (GLOBE NEWSWIRE) -- SpeeDx Pty. Ltd. today announced the start of patient testing in their multisite U.S.-based clinical trials for ResistancePlus® MG (not available for sale in the U.S.). The molecular diagnostic test detects the sexually transmitted infection (STI) Mycoplasma genitalium, also known as Mgen or MG, along with genetic markers linked to antibiotic resistance. In recent years, Mgen prevalence has increased globally and developed high rates of resistance to the common antibiotic treatment, azithromycin. "This test is an exciting new development that will increase the precision of patient care for patients impacted by Mycoplasma genitalium - a common sexually transmitted infection with limited treatment options,” notes Dr Maria Trent, Professor of Pediatrics and Public Health at Johns Hopkins Medicine. The SpeeDx ResistancePlus MG test is in use in laboratories acr

Novavax Initiates Phase 2 Clinical Trial of NanoFlu™ in Older Adults25.9.2018 13:00Pressemelding

First participants enrolled in Phase 2 clinical trial of quadrivalent NanoFlu formulations Top-line immunogenicity and safety data expected in the first quarter of 2019 Phase 2 results will support meeting with the U.S. Food and Drug Administration (FDA) and Phase 3 clinical trial design GAITHERSBURG, Md., Sept. 25, 2018 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX) today announced the initiation of a Phase 2 dose and formulation confirmation clinical trial in older adults of NanoFlu, its nanoparticle seasonal influenza vaccine candidate. “Initiating this Phase 2 clinical trial of NanoFlu is an important milestone for Novavax,” said Stanley C. Erck, President and Chief Executive Officer of Novavax. “With top-line results expected in the first quarter of 2019, we plan to discuss these data with the FDA at an ‘End of Phase 2’ meeting and to agree on the appropriate Phase 3 clinical trial design to support licensure via accelerated approval. We continue to believe NanoFlu is a differen

CGAP Launches Photo and Video Contest Theme for 2018: Financial Inclusion in Africa25.9.2018 13:00Pressemelding

This year's CGAP contest is the first ever to accept short video entries WASHINGTON, Sept. 25, 2018 (GLOBE NEWSWIRE) -- The Consultative Group to Assist the Poor’s (CGAP) 13th annual photo contest, launched today, is seeking striking images on financial inclusion in Africa. For the first time, short video submissions on Africa also will be accepted. Entries may be submitted through December 14, 2018. Each contestant may submit up to 20 photos or videos to compete for the Grand Prize worth US$ 2,000. This year CGAP is looking for original and compelling photographs and short videos that tell the story of how financial services empower poor people and communities in Africa. The region is a center for financial innovation -- home to M-Pesa, the mobile money service launched a decade ago now replicated across markets worldwide; host to vibrant FinTech and e-commerce companies; and to a growing off-grid sector that leverages digital finance. Together these innovators contribute toward lifti

Kick-starting health in the workplace25.9.2018 10:00Pressemelding

Over 800 organizations step, bike, swim and yoga their way to better health and wellbeing as the May 2018 Virgin Pulse Global Challenge Concludes ZURICH, Switzerland, Sept. 25, 2018 (GLOBE NEWSWIRE) -- On August 30th more than 270,000 people, across 144 countries, completed Virgin Pulse’s 100-day Global Challenge, moving them towards a more active, healthy and productive lifestyle. With this achievement, Virgin Pulse, an international leader in employee health and wellbeing, once again proves it’s helping to improve employee lives for good. The company’s Global Challenge event encourages exercise, mindfulness and healthy habits at work, leading to a happier culture and reduced costs to the organization. “Through increased awareness, education and motivation, employees master long-term, sustainable habits allowing them to arrive at work feeling more engaged, productive and equipped for peak performance,” says David Osborne, Chief Executive Officer of Virgin Pulse. “The follow-on effects

GridGain Unveils Keynote Schedule for Fourth Annual In-Memory Computing Summit North America25.9.2018 09:00Pressemelding

Oracle Becomes Platinum Conference Sponsor FOSTER CITY, Calif., Sept. 25, 2018 (GLOBE NEWSWIRE) -- GridGain® Systems, provider of enterprise-grade in-memory computing solutions based on Apache® Ignite™, today announced the keynote speaker schedule for the fourth annual In-Memory Computing Summit® North America, taking place October 2-3, 2018 at the Hyatt Regency San Francisco Airport. Industry luminaries from ING Belgium, Wellington Management, Oracle, SNIA and GridGain Systems will discuss the evolution of in-memory computing technology and how organizations are leveraging in-memory computing to obtain the speed and scalability necessary for their digital transformation, omnichannel customer experience, Big Data and Fast Data initiatives. GridGain today also announced that Oracle has become a Platinum conference sponsor. The In-Memory Computing Summit North America 2018 is the only in-memory computing conference focusing on the full range of in-memory computing-related technologies an

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom